U.S. Banks Stock News

NasdaqCM:QUIK
NasdaqCM:QUIKSemiconductor

QuickLogic (QUIK) Q1 Losses Persist Despite Higher Revenue Challenging Bullish Profitability Narratives

QuickLogic (QUIK) opened Q1 2026 with revenue of about US$5.1 million and a basic EPS loss of US$0.13, setting the tone for another quarter where the top line and per share results remain firmly in focus for investors who track the stock through earnings season. Over the past year, the company has reported quarterly revenue in a range of roughly US$2.0 million to US$5.7 million, while basic EPS has ranged from a small profit of about US$0.01 per share to a quarterly loss of about US$0.24 per...
NasdaqGS:PWP
NasdaqGS:PWPCapital Markets

How Investors May Respond To Perella Weinberg Partners (PWP) Profit Drop, Dividend Hold And Expanded CFO Role

Perella Weinberg Partners recently reported first-quarter 2026 results showing net income of US$1.49 million, down sharply from US$17.34 million a year earlier, while also affirming a quarterly dividend of US$0.07 per Class A share payable in June. Alongside the weaker quarter, the firm expanded Chief Financial Officer Alexandra Gottschalk’s remit to include Chief Operating Officer, highlighting a tighter focus on operational execution as management cited longer timelines to complete complex...
NasdaqGS:HAS
NasdaqGS:HASLeisure

Hasbro (HAS) Q1 Profit Challenges Ongoing Trailing Twelve Month Loss Narrative

Hasbro’s Q1 2026 earnings in focus Hasbro (HAS) opened 2026 with Q1 revenue of US$1,000.2 million and basic EPS of US$1.41, setting a clear snapshot of the business against a current share price of US$95.65. Over recent quarters the company has seen revenue move from US$887.1 million in Q1 2025 to US$1,000.2 million in Q1 2026, while basic EPS shifted from US$0.71 to US$1.41 over the same period. This gives investors a clearer look at how the top line and per share earnings are tracking. With...
NYSEAM:LCTX
NYSEAM:LCTXBiotechs

Lineage Cell Therapeutics (LCTX) Returns To Loss In Q1 2026 Challenging Profitability Narratives

Lineage Cell Therapeutics (LCTX) opened 2026 with Q1 revenue of US$1.7 million and a basic EPS loss of US$0.02, as net income excluding extraordinary items came in at a loss of US$4.8 million. The company has seen quarterly revenue move between US$1.5 million and US$6.6 million over the past year, while EPS has ranged from a loss of around US$0.13 per share to a small profit of US$0.00 per share, presenting a mixed picture regarding the path toward better margins. For investors, the latest...
NYSEAM:ESP
NYSEAM:ESPElectrical

Espey Mfg. & Electronics (ESP) Non Cash Heavy 25.5% Margin Challenges Bullish Earnings Narratives

Espey Mfg. & Electronics (ESP) has reported another solid set of Q3 2026 numbers, with revenue of about US$11.4 million and basic EPS of roughly US$1.03, supported by trailing 12 month EPS of US$3.95 on revenue of around US$42.2 million. The company has seen quarterly revenue range between US$9.1 million and US$13.6 million over the past six periods, while basic EPS has moved between US$0.66 and US$1.10. This sets up the latest quarter against a backdrop of higher trailing earnings growth and...
NasdaqGS:MXCT
NasdaqGS:MXCTLife Sciences

MaxCyte (MXCT) EPS Loss Narrows In Q1 2026 Challenging Bearish Profitability Narratives

MaxCyte (NasdaqGS:MXCT) opened Q1 2026 with revenue of US$9.7 million and a basic EPS loss of US$0.04, while trailing 12 month figures show revenue of US$32.3 million and a basic EPS loss of US$0.37. The company has seen quarterly revenue move from US$10.4 million in Q1 2025 to US$9.7 million in Q1 2026, with net income moving from a loss of US$10.3 million to a loss of US$4.8 million over the same period. These figures frame the discussion for investors who are focused on how margins develop...
NYSE:CMDB
NYSE:CMDBShipping

Costamare Bulkers Holdings (CMDB) Q1 Profitability Challenges Longstanding Bearish Earnings Narratives

Costamare Bulkers Holdings (NYSE:CMDB) has opened 2026 with Q1 revenue of US$111.5 million, basic EPS of US$0.41 and net income of US$9.9 million, setting a clearer profit picture against a share price of US$19.02. The company has previously reported quarterly revenue figures ranging from US$222.9 million to US$318.9 million and a mix of positive and loss making EPS and net income results, so this quarter slots into a track record that already includes periods of pressure on earnings quality...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Profitable AI Stocks One Debt Free Earner One Quiet Chip Powerhouse

AI spending is no longer just a race to build the biggest models; it is increasingly about which companies can turn that investment into real earnings. With inflation pressures touching everything from fuel to freight, and central banks keeping rates higher for longer, cash generation and pricing power matter more than ever. The Profitable AI Stocks screener focuses on businesses already using AI to support profits rather than just promises. This article highlights 3 stocks from that list...
NasdaqGM:CAMT
NasdaqGM:CAMTSemiconductor

Camtek (CAMT) Q1 2026 EPS Reset Tests Bullish AI Margin Narratives

Camtek (NasdaqGM:CAMT) sets the tone with Q1 2026 earnings Camtek (NasdaqGM:CAMT) opened 2026 with Q1 revenue of US$121.7 million and basic EPS of US$0.68, setting a clear marker for how the year is starting to shape up. The company has seen revenue move from US$117.3 million in Q4 2024 to US$128.1 million in Q4 2025, with basic EPS across those periods ranging from US$0.73 to US$0.78, while trailing 12 month EPS sits at US$1.05 on revenue of US$499.1 million. With a trailing net margin of...
NasdaqCM:PAYS
NasdaqCM:PAYSDiversified Financial

Is Paysign’s (PAYS) Affordability Shift Redefining Its Core Profit Engine?

Paysign, Inc. reported past first-quarter 2026 results on May 12, posting revenue of US$28.04 million and net income of US$5.44 million, with diluted EPS of US$0.09 from continuing operations. The quarter marked a shift as patient affordability programs became Paysign’s largest revenue contributor, reflecting a mix change toward higher-margin pharma offerings. We’ll now examine how this record first quarter and the rise of patient affordability as Paysign’s largest revenue stream affect its...
NasdaqGS:AFRM
NasdaqGS:AFRMDiversified Financial

Affirm Google Pay Tie Up Sparks Questions On Growth And Valuation

Affirm Holdings (NasdaqGS:AFRM) is expanding its partnership with Google to embed buy now, pay later options into Google Search results and the Gemini app via Google Pay. The new integration brings Affirm's pay over time product directly into shopping journeys for hundreds of millions of Google users. This development broadens Affirm's reach with consumers and merchants inside a core part of the global digital shopping and search experience. Affirm operates a buy now, pay later platform...
NasdaqGS:SOLS
NasdaqGS:SOLSChemicals

Solstice Advanced Materials (SOLS) Valuation Check After Q1 Earnings And Updated Guidance

Q1 earnings and guidance put Solstice Advanced Materials (SOLS) in focus Solstice Advanced Materials (SOLS) has come into focus after reporting first quarter 2026 earnings showing revenue of US$991 million and net income of US$85 million, alongside fresh second quarter and full year net sales guidance. See our latest analysis for Solstice Advanced Materials. At a share price of US$86.81, Solstice Advanced Materials has seen a 7 day share price return of 11.64% and a year to date share price...
NYSE:BETA
NYSE:BETAAerospace & Defense

BETA Technologies Advances FAA Programs As Stock Trades Below Valuation Estimates

BETA Technologies (NYSE:BETA) was selected for seven of eight FAA eVTOL Integration Pilot Programs in the past week. The company received a commercial aircraft order from Surf Air Mobility, expanding its confirmed backlog. BETA launched cargo and medical operations and advanced partnerships with GE Aerospace and General Dynamics. The company continued to roll out its nationwide charging network to support electric aviation operations. At a share price of $16.61, NYSE:BETA has had a tough...
NasdaqCM:SLNH
NasdaqCM:SLNHSoftware

Does Soluna Holdings' (SLNH) Modest Shelf Raise Reveal Its Evolving Capital Strategy in Crypto Infrastructure?

Soluna Holdings, Inc. recently closed its April 29, 2026 shelf registration, raising US$2.66 million through the offering of 2,459,400 shares of common stock. This completed shelf registration, alongside ongoing SEC filings, highlights the company’s continued effort to secure funding for its cryptocurrency mining and data center activities. Next, we’ll consider how Soluna’s recent capital raise via this shelf registration closing shapes the company’s broader investment narrative. Uncover the...
NasdaqGS:WEN
NasdaqGS:WENHospitality

Is Wendy’s (WEN) Short Term Rally Creating A Fresh Opportunity For Investors

This article examines whether Wendy's stock at US$8.11 is a bargain or a value trap by focusing on what the numbers indicate about its current price. The stock has recently risen 16.7% over the past 7 days and 19.6% over the past 30 days, although returns are still down 0.7% year to date and down 27.9% over the past year. Recent coverage has centered on Wendy's longer term share price performance, with 3 year and 5 year returns down 59.1% and 57.5% respectively. This has kept sentiment...
NasdaqGM:AIP
NasdaqGM:AIPSoftware

Arteris (AIP) Revenue Growth With Persistent EPS Loss Tests Bullish Narratives In Q1 2026

Arteris (AIP) has opened Q1 2026 with revenue of US$22.9 million and a basic EPS loss of US$0.17, setting the tone for another growth focused but loss making quarter. The company has seen quarterly revenue move from US$16.5 million in Q1 2025 to US$22.9 million in Q1 2026, while basic EPS losses have ranged between US$0.21 and US$0.17 over the same period, which keeps the spotlight firmly on how efficiently that top line is being converted. With revenue expansion set against ongoing losses,...
NYSE:VLN
NYSE:VLNSemiconductor

Why Valens Semiconductor (VLN) Is Up 18.0% After Beating Q1 Targets And Reaffirming 2026 Guidance

Valens Semiconductor recently reported past first-quarter 2026 results, with revenues of US$16.86 million, a net loss of US$8.29 million, and GAAP gross margin of 62.2%, while reiterating full-year revenue guidance of US$75 million to US$77 million. Management highlighted stronger-than-expected demand for its VS3000 and VS6320 chipsets and signaled a more confident outlook for second-half 2026 growth across audio-video and automotive connectivity markets. We’ll now examine how beating Q1...
NYSE:SUN
NYSE:SUNOil and Gas

Should Sunoco’s (SUN) Surging Q1 Revenue and Profit Require Action From Existing Investors?

In the first quarter ended March 31, 2026, Sunoco LP reported sales of US$10.69 billion and net income of US$644 million, up from US$5.18 billion and US$207 million a year earlier, with basic earnings per share from continuing operations rising to US$2.86 from US$1.22. This sharp expansion in both revenue and profit suggests Sunoco converted higher fuel volumes or pricing into much stronger earnings efficiency compared with the prior-year period. Now we’ll examine how this sharp earnings...
NasdaqGS:ZBRA
NasdaqGS:ZBRAElectronic

Zebra Technologies (ZBRA) Margin Compression Challenges Bullish Earnings Narrative After Q1 2026 Results

Q1 2026 earnings snapshot Zebra Technologies (ZBRA) has opened Q1 2026 with revenue of US$1.5b and basic EPS of US$2.75, setting a clear marker for how the year is starting to shape up. The company has seen quarterly revenue move from US$1.31b in Q1 2025 to US$1.50b in Q1 2026, while basic EPS over the same quarters went from US$2.65 to US$2.75. This gives investors a clear view of how the top and bottom lines are tracking year on year. With trailing 12 month net profit margins sitting below...
NYSE:DOCS
NYSE:DOCSHealthcare Services

Doximity Ties Clinical AI To Aledade And New Pharma Search Revenue

Doximity (NYSE:DOCS) has partnered with Aledade to plug its HIPAA-compliant Clinical AI Suite, including Scribe and Ask, into Aledade’s EHR overlay platform. The integration targets value-based primary care and independent practices, aiming to streamline documentation and surface clinical insights at the point of care. Doximity has also begun monetizing its AI-driven search product for pharmaceutical marketers, opening a new revenue channel tied to digital promotion budgets. Doximity,...
NasdaqGS:WAFD
NasdaqGS:WAFDBanks

Is WaFd (WAFD) Fairly Priced After Its 21.2% One Year Share Price Gain

With WaFd on many watchlists, the key question is whether the recent share price reflects a fair deal or if there is still value on the table. At a last close of US$34.59, the stock is down 2.9% over the past week, up 5.7% over the past month, and has returned 21.2% over the past year, which can change how investors think about both upside potential and risk. Recent coverage has focused on WaFd's position in the US regional banking space and how investors are reacting to sector specific...
NasdaqCM:INVZ
NasdaqCM:INVZElectronic

Assessing Innoviz Technologies (INVZ) Valuation After New LiDAR Partnerships And Autonomous Vehicle Progress

Why recent LiDAR partnerships matter for Innoviz Technologies (NasdaqCM:INVZ) Recent announcements around InnovizTwo evaluations set the stage for Innoviz Technologies (NasdaqCM:INVZ), including an on-sensor perception software agreement and a separate letter of intent with LOXO for L4 autonomous delivery vehicles. See our latest analysis for Innoviz Technologies. These new LiDAR evaluation agreements come as momentum has picked up in the short term, with 1 day, 7 day and 30 day share price...